Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Debt Ratio: 2009-2025

Historic Debt Ratio for Aytu Biopharma (AYTU) over the last 14 years, with Sep 2025 value amounting to 0.20.

  • Aytu Biopharma's Debt Ratio rose 59.63% to 0.20 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63, marking a year-over-year increase of 23.60%. This contributed to the annual value of 0.16 for FY2025, which is 43.01% up from last year.
  • Per Aytu Biopharma's latest filing, its Debt Ratio stood at 0.20 for Q3 2025, which was up 26.04% from 0.16 recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Debt Ratio ranged from a high of 0.20 in Q3 2025 and a low of 0.06 during Q1 2021.
  • Over the past 3 years, Aytu Biopharma's median Debt Ratio value was 0.12 (recorded in 2023), while the average stood at 0.14.
  • Per our database at Business Quant, Aytu Biopharma's Debt Ratio skyrocketed by 889.97% in 2021 and then fell by 21.47% in 2023.
  • Over the past 5 years, Aytu Biopharma's Debt Ratio (Quarterly) stood at 0.07 in 2021, then surged by 111.00% to 0.16 in 2022, then decreased by 21.47% to 0.12 in 2023, then fell by 1.25% to 0.12 in 2024, then spiked by 59.63% to 0.20 in 2025.
  • Its Debt Ratio was 0.20 in Q3 2025, compared to 0.16 in Q2 2025 and 0.16 in Q1 2025.